ATXS vs KEYS · rev $706.0K vs P/E 57, rev $5.16B
Astria Therapeutics Inc (ATXS) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported KEYS revenue for 2026-07-31 was $5.16B. Net income was $1.03B. Revenue was up 55.7% from 2026-04-30 to 2026-07-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
ATXS currently screens at market cap $382.1M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the ATXS and KEYS stock pages for the full models.
Not investment advice.